Literature DB >> 27599408

Argument for the conservative management of mandibular ameloblastomas.

Jahrad Haq1, Sarah Siddiqui2, Mark McGurk3.   

Abstract

Ameloblastoma is a rare, benign, odontogenic tumour that affects the mandible more commonly than the maxilla. Solid or multicytic variants are often resected and the defects reconstructed with a free flap. To establish the outcome after enucleation and application of Carnoy's solution, irrespective of histological subtype, we used the hospital's histology database to identify all the patients treated between 2001 and 2014 by one surgeon. Variables included patients' characteristics, histological subtype, radiological appearance, follow-up period, and incidence of recurrence. A total of 27 patients (13 male) were included, mean age 41 years (range 12-79). Fifteen (56%) had solid multicystic lesions, and there was an overall predominance of the follicular or plexiform variant, or both. Of the 23 preoperative radiographs that were available, 17 lesions were unicystic, 5 multilobular and scalloped with no septa, and one had aggressive features of multilocularity and a poorly defined peripheral margin. The mean duration of follow up was 38 months (range 3-156). Three patients had recurrence at 20, 27, and 35 months postoperatively, and each had repeat enucleation and application of Carnoy's solution. Reconstruction was not necessary, and to date none has recurred. This study shows the potential benefits of conservative surgery and sterilisation of the cystic cavity with Carnoy's solution. Recurrence is low, and with vigilant surveillance, similar repeat procedures have been effective when necessary. A longer follow-up period and larger numbers of patients are now needed to corroborate these findings. Copyright Â
© 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Ameloblastoma; Carnoy's; Enucleation

Mesh:

Year:  2016        PMID: 27599408     DOI: 10.1016/j.bjoms.2016.07.017

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  7 in total

1.  Is conservative surgery a better choice for the solid/multicystic ameloblastoma than radical surgery regarding recurrence? A systematic review.

Authors:  Yuri Slusarenko da Silva; Natalia Aguiar Tartaroti; Daniel Isaac Sendyk; Maria Cristina Zindel Deboni; Maria da Graça Naclério-Homem
Journal:  Oral Maxillofac Surg       Date:  2018-09-06

2.  Conservative surgical treatment for ameloblastoma: a report of three cases.

Authors:  Se-Won Kim; Yu-Jin Jee; Deok-Won Lee; Hyung Kyung Kim
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2018-10-26

Review 3.  Surgical Margins for Ameloblastoma in Dogs: A Review With an Emphasis on the Future.

Authors:  Stephanie Goldschmidt
Journal:  Front Vet Sci       Date:  2022-03-22

4.  Clinical evaluation of fenestration decompression combined with secondary curettage for ameloblastoma of the jaw: retrospective radiographic analysis.

Authors:  Kailiu Wu; Hao Luo; Zhuang Yuan; Yanan Wang; Xing Qin; Jie He
Journal:  BMC Oral Health       Date:  2022-10-14       Impact factor: 3.747

5.  Ameloblastoma Management: "Horses for Courses" Protocol.

Authors:  Suresh Menon; Veerendra Kumar; S Archana; Priyangana Nath; Satyapriya Shivakotee; Mahbubul Hoda
Journal:  J Maxillofac Oral Surg       Date:  2019-01-23

6.  Tomoelastography for non-invasive detection of ameloblastoma and metastatic neck lymph nodes.

Authors:  Marie Beier; Ingolf Sack; Benedicta Beck-Broichsitter; Bernd Hamm; Stephan Rodrigo Marticorena Garcia
Journal:  BMJ Case Rep       Date:  2020-09-09

7.  Recurrence and cancerization of ameloblastoma: multivariate analysis of 87 recurrent craniofacial ameloblastoma to assess risk factors associated with early recurrence and secondary ameloblastic carcinoma.

Authors:  Rong Yang; Zheqi Liu; Sandhya Gokavarapu; Canbang Peng; Tong Ji; Wei Cao
Journal:  Chin J Cancer Res       Date:  2017-06       Impact factor: 5.087

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.